CD4 0 3 0 3 B-clinical_variable
T 4 5 4 5 I-clinical_variable
cell 6 10 6 10 I-clinical_variable
count 11 16 11 16 I-clinical_variable
â‰¥ 17 18 17 18 O
400 19 22 19 22 B-lower_bound
cells 23 28 23 28 I-lower_bound
/ 28 29 28 29 I-lower_bound
mm3 29 32 29 32 I-lower_bound

Documented 0 10 33 43 O
suppressed 11 21 44 54 O
HIV-1 22 27 55 60 B-chronic_disease
RNA 28 31 61 64 B-clinical_variable
( 32 33 65 66 O
plasma 33 39 66 72 B-clinical_variable
HIV-1 40 45 73 78 I-clinical_variable
RNA 46 49 79 82 I-clinical_variable
values 50 56 83 89 I-clinical_variable
< 57 58 90 91 O
50 58 60 91 93 B-upper_bound
copies 61 67 94 100 I-upper_bound
/ 67 68 100 101 I-upper_bound
ml 68 70 101 103 I-upper_bound
) 70 71 103 104 O

Evidence 0 8 105 113 O
of 9 11 114 116 O
coronary 12 20 117 125 B-chronic_disease
heart 21 26 126 131 I-chronic_disease
disease 27 34 132 139 I-chronic_disease

Female 0 6 140 146 B-gender
participants 7 19 147 159 I-gender
who 20 23 160 163 O
are 24 27 164 167 B-pregnancy
pregnant 28 36 168 176 I-pregnancy

HIV-1 0 5 177 182 B-clinical_variable
RNA 6 9 183 186 I-clinical_variable
> 10 11 187 188 O
50 12 14 189 191 B-lower_bound
copies 15 21 192 198 I-lower_bound
/ 21 22 198 199 I-lower_bound
mL 22 24 199 201 I-lower_bound
within 25 31 202 208 O
24 32 34 209 211 B-upper_bound
months 35 41 212 218 I-upper_bound
of 42 44 219 221 O
screening 45 54 222 231 O

HIV-1 0 5 232 237 B-chronic_disease
infection 6 15 238 247 O
prior 16 21 248 253 O
to 22 24 254 256 O
entry 25 30 257 262 O

Has 0 3 263 266 O
taken 4 9 267 272 O
: 9 10 272 273 O
interleukins 11 23 274 286 B-treatment
, 23 24 286 287 O
systemic 25 33 288 296 B-treatment
interferons 34 45 297 308 I-treatment
or 46 48 309 311 O
systemic 49 57 312 320 B-treatment
chemotherapy 58 70 321 333 I-treatment

History 0 7 334 341 O
of 8 10 342 344 O
active 11 17 345 351 B-chronic_disease
thyroid 18 25 352 359 I-chronic_disease
disease 26 33 360 367 I-chronic_disease
requiring 34 43 368 377 O
medication 44 54 378 388 O

History 0 7 389 396 O
of 8 10 397 399 O
anaphylaxis 11 22 400 411 O
, 22 23 411 412 O
allergy 24 31 413 420 O
or 32 34 421 423 O
serious 35 42 424 431 O
adverse 43 50 432 439 O
reactions 51 60 440 449 O
to 61 63 450 452 O
Interferon 64 74 453 463 B-allergy_name
- 74 75 463 464 I-allergy_name
alpha2a 75 82 464 471 I-allergy_name
/ 82 83 471 472 O
Interferon 83 93 472 482 B-allergy_name
- 93 94 482 483 I-allergy_name
alpha2b 94 101 483 490 I-allergy_name
or 102 104 491 493 O
panobinostat 105 117 494 506 B-allergy_name

History 0 7 507 514 O
of 8 10 515 517 O
malignancy 11 21 518 528 B-cancer
of 22 24 529 531 O
any 25 28 532 535 O
organ 29 34 536 541 O
system 35 41 542 548 O
within 42 48 549 555 O
the 49 52 556 559 O
past 53 57 560 564 B-upper_bound
5 58 59 565 566 I-upper_bound
years 60 65 567 572 I-upper_bound

History 0 7 573 580 O
of 8 10 581 583 O
solid 11 16 584 589 B-treatment
organ 17 22 590 595 I-treatment
transplantation 23 38 596 611 I-treatment
with 39 43 612 616 I-treatment
an 44 46 617 619 I-treatment
existing 47 55 620 628 I-treatment
functional 56 66 629 639 I-treatment
graft 67 72 640 645 I-treatment

History 0 7 646 653 O
or 8 10 654 656 O
other 11 16 657 662 O
evidence 17 25 663 671 O
of 26 28 672 674 O
severe 29 35 675 681 B-chronic_disease
illness 36 43 682 689 I-chronic_disease
or 44 46 690 692 O
other 47 52 693 698 O
conditions 53 63 699 709 O

If 0 2 710 712 O
male 3 7 713 717 B-gender
, 7 8 717 718 O
willingness 9 20 719 730 O
to 21 23 731 733 O
use 24 27 734 737 B-contraception_consent
a 28 29 738 739 I-contraception_consent
condom 30 36 740 746 I-contraception_consent
during 37 43 747 753 I-contraception_consent
intercourse 44 55 754 765 I-contraception_consent
while 56 61 766 771 O
taking 62 68 772 778 O
panobinostat 69 81 779 791 B-treatment
and 82 85 792 795 O
total 86 91 796 801 O
of 92 94 802 804 O
80 95 97 805 807 O
hours 98 103 808 813 O
after 104 109 814 819 O
stopping 110 118 820 828 O
treatment 119 128 829 838 B-treatment

Negative 0 8 839 847 O
Hepatitis 9 18 848 857 B-chronic_disease
B 19 20 858 859 I-chronic_disease
surface 21 28 860 867 I-chronic_disease
antigen 29 36 868 875 I-chronic_disease
( 37 38 876 877 I-chronic_disease
HBsAg 38 43 877 882 I-chronic_disease
) 43 44 882 883 I-chronic_disease
or 45 47 884 886 O
Negative 48 56 887 895 O
HBV 57 60 896 899 O
DNA 61 64 900 903 O
PCR 65 68 904 907 O

Negative 0 8 908 916 O
TB 9 11 917 919 B-chronic_disease
Test 12 16 920 924 O
( 17 18 925 926 O
if 18 20 926 928 O
positive 21 29 929 937 O
, 29 30 937 938 O
completed 31 40 939 948 O
a 41 42 949 950 O
recommended 43 54 951 962 O
treatment 55 64 963 972 B-treatment
course 65 71 973 979 O
for 72 75 980 983 O
latent 76 82 984 990 O
TB 83 85 991 993 O
) 85 86 993 994 O

No 0 2 995 997 O
clinically 3 13 998 1008 O
significant 14 25 1009 1020 O
eye 26 29 1021 1024 B-chronic_disease
disease 30 37 1025 1032 I-chronic_disease

No 0 2 1033 1035 O
evidence 3 11 1036 1044 O
of 12 14 1045 1047 O
clinical 15 23 1048 1056 O
coronary 24 32 1057 1065 B-chronic_disease
heart 33 38 1066 1071 I-chronic_disease
disease 39 46 1072 1079 I-chronic_disease

No 0 2 1080 1082 O
evidence 3 11 1083 1091 O
of 12 14 1092 1094 O
coronary 15 23 1095 1103 B-chronic_disease
heart 24 29 1104 1109 I-chronic_disease
disease 30 37 1110 1117 I-chronic_disease

Not 0 3 1118 1121 B-pregnancy
pregnant 4 12 1122 1130 I-pregnancy

Presence 0 8 1131 1139 O
of 9 11 1140 1142 O
a 12 13 1143 1144 O
bacterial 14 23 1145 1154 B-chronic_disease
, 23 24 1154 1155 O
fungal 25 31 1156 1162 B-chronic_disease
, 31 32 1162 1163 O
viral 33 38 1164 1169 B-chronic_disease
or 39 41 1170 1172 O
protozoal 42 51 1173 1182 B-chronic_disease
infection 52 61 1183 1192 I-chronic_disease
requiring 62 71 1193 1202 O
systemic 72 80 1203 1211 B-treatment
anti 81 85 1212 1216 I-treatment
- 85 86 1216 1217 I-treatment
infective 86 95 1217 1226 I-treatment
therapy 96 103 1227 1234 I-treatment

Receiving 0 9 1235 1244 O
suppressive 10 21 1245 1256 O
ART 22 25 1257 1260 B-treatment
therapy 26 33 1261 1268 I-treatment
for 34 37 1269 1272 O
a 38 39 1273 1274 O
minimum 40 47 1275 1282 O
of 48 50 1283 1285 O
24 51 53 1286 1288 B-lower_bound
consecutive 54 65 1289 1300 I-lower_bound
months 66 72 1301 1307 I-lower_bound
prior 73 78 1308 1313 I-lower_bound
to 79 81 1314 1316 O
screening 82 91 1317 1326 O
with 92 96 1327 1331 O
no 97 99 1332 1334 O
interruption 100 112 1335 1347 O
of 113 115 1348 1350 O
therapy 116 123 1351 1358 O
( 124 125 1359 1360 O
same 125 129 1360 1364 O
ART 130 133 1365 1368 O
regimen 134 141 1369 1376 O
for 142 145 1377 1380 O
at 146 148 1381 1383 O
least 149 154 1384 1389 O
12 155 157 1390 1392 B-lower_bound
weeks 158 163 1393 1398 I-lower_bound
prior 164 169 1399 1404 I-lower_bound
to 170 172 1405 1407 O
screening 173 182 1408 1417 O
) 182 183 1417 1418 O

Severe 0 6 1419 1425 O
psychiatric 7 18 1426 1437 B-chronic_disease
disease 19 26 1438 1445 I-chronic_disease

Severe 0 6 1446 1452 O
retinopathy 7 18 1453 1464 B-chronic_disease
due 19 22 1465 1468 O
to 23 25 1469 1471 O
diabetes 26 34 1472 1480 B-chronic_disease
, 34 35 1480 1481 O
hypertension 36 48 1482 1494 B-chronic_disease
, 48 49 1494 1495 O
cytomegalovirus 50 65 1496 1511 B-chronic_disease
or 66 68 1512 1514 O
macular 69 76 1515 1522 B-chronic_disease
degeneration 77 89 1523 1535 I-chronic_disease

Uncontrolled 0 12 1536 1548 O
seizure 13 20 1549 1556 B-chronic_disease
disorders 21 30 1557 1566 I-chronic_disease

Use 0 3 1567 1570 O
of 4 6 1571 1573 O
HIV 7 10 1574 1577 B-treatment
protease 11 19 1578 1586 I-treatment
inhibitor 20 29 1587 1596 I-treatment
or 30 32 1597 1599 O
other 33 38 1600 1605 O
strong 39 45 1606 1612 O
or 46 48 1613 1615 O
moderately 49 59 1616 1626 O
strong 60 66 1627 1633 O
CYP3A4 67 73 1634 1640 B-treatment
inhibitors 74 84 1641 1651 I-treatment

Use 0 3 1652 1655 O
of 4 6 1656 1658 O
any 7 10 1659 1662 O
immunomodulatory 11 27 1663 1679 B-treatment
agents 28 34 1680 1686 I-treatment
within 35 41 1687 1693 O
30 42 44 1694 1696 B-upper_bound
days 45 49 1697 1701 I-upper_bound
prior 50 55 1702 1707 I-upper_bound
to 56 58 1708 1710 O
study 59 64 1711 1716 O
enrollment 65 75 1717 1727 O
or 76 78 1728 1730 O
planned 79 86 1731 1738 O
use 87 90 1739 1742 O
during 91 97 1743 1749 O
the 98 101 1750 1753 O
trial 102 107 1754 1759 O

Vaccinated 0 10 1760 1770 O
for 11 14 1771 1774 O
pneumococcal 15 27 1775 1787 B-chronic_disease
disease 28 35 1788 1795 I-chronic_disease
within 36 42 1796 1802 O
last 43 47 1803 1807 B-upper_bound
5 48 49 1808 1809 I-upper_bound
years 50 55 1810 1815 I-upper_bound

Willingness 0 11 1816 1827 B-contraception_consent
to 12 14 1828 1830 I-contraception_consent
continue 15 23 1831 1839 I-contraception_consent
to 24 26 1840 1842 I-contraception_consent
use 27 30 1843 1846 I-contraception_consent
contraceptives 31 45 1847 1861 I-contraception_consent
for 46 49 1862 1865 O
90 50 52 1866 1868 B-upper_bound
days 53 57 1869 1873 I-upper_bound
after 58 63 1874 1879 O
completing 64 74 1880 1890 O
treatment 75 84 1891 1900 B-treatment

chronic 0 7 1901 1908 O
liver 8 13 1909 1914 B-chronic_disease
disease 14 21 1915 1922 I-chronic_disease

negative 0 8 1923 1931 O
HCV 9 12 1932 1935 B-chronic_disease
PCR 13 16 1936 1939 O
if 17 19 1940 1942 O
anti 20 24 1943 1947 O
- 24 25 1947 1948 O
HCV 25 28 1948 1951 O
antibodies 29 39 1952 1962 O
are 40 43 1963 1966 O
positive 44 52 1967 1975 O

past 0 4 1976 1980 O
or 5 7 1981 1983 O
current 8 15 1984 1991 O
evidence 16 24 1992 2000 O
of 25 27 2001 2003 O
immunologically 28 43 2004 2019 B-chronic_disease
mediated 44 52 2020 2028 I-chronic_disease
disease 53 60 2029 2036 I-chronic_disease

planning 0 8 2037 2045 O
to 9 11 2046 2048 O
become 12 18 2049 2055 B-pregnancy
pregnant 19 27 2056 2064 I-pregnancy

